Page 68 - GTM-2-4

Global Translational Medicine Epigenetics on cardiovascular diseases

https://doi.org/10.1007/s40291-017-0314-8 111. Dasgupta I, Chatterjee A, 2021, Recent advances in miRNA
delivery systems. Methods Protoc, 4: 10.
100. Neppl RL, Wang DZ, 2014, The myriad essential roles of
microRNAs in cardiovascular homeostasis and disease. https://doi.org/10.3390/mps4010010
Genes Dis, 1: 18–39.
112. Hong T, Wei Y, Xue X, et al., 2020, A novel anti-coagulative
https://doi.org/10.1016/j.gendis.2014.06.003 nanocomplex in delivering miRNA-1 inhibitor against
microvascular obstruction of myocardial infarction. Adv
101. Wronska A, Kurkowska-Jastrzebska I, Santulli G, 2015,
Application of microRNAs in diagnosis and treatment of Healthc Mater, 9: e1901783.
cardiovascular disease. Acta Physiol (Oxf), 213: 60–83. https://doi.org/10.1002/adhm.201901783
https://doi.org/10.1111/apha.12416 113. Bejerano T, Etzion S, Elyagon S, et al., 2018, Nanoparticle
delivery of miRNA-21 mimic to cardiac macrophages
102. Wronska A, 2023, The role of microRNA in the development,
diagnosis, and treatment of cardiovascular disease: Recent improves myocardial remodeling after myocardial
developments. J Pharmacol Exp Ther, 384: 123–132. infarction. Nano Lett, 18: 5885–5891.
https://doi.org/10.1021/acs.nanolett.8b02578
https://doi.org/10.1124/jpet.121.001152
114. Feng YH, Tsao CJ, 2016, Emerging role of microRNA-21 in
103. Griesemer D, Xue JR, Reilly SK, et al., 2021, Genome-wide
functional screen of 3’UTR variants uncovers causal variants cancer. Biomed Rep, 5: 395–402.
for human disease and evolution. Cell, 184: 5247–5260.e19. https://doi.org/10.3892/br.2016.747
https://doi.org/10.1016/j.cell.2021.08.025 115. Bielska A, Niemira M, Bauer W, et al., 2022, Serum miRNA
profile in diabetic patients with ischemic heart disease as
104. Maries L, Marian C, Sosdean R, et al., 2021, MicroRNAs-the
heart of post-myocardial infarction remodeling. Diagnostics a promising non-invasive biomarker. Front Endocrinol
(Basel), 11: 1675. (Lausanne), 13: 888948.
https://doi.org/10.3389/fendo.2022.888948
https://doi.org/10.3390/diagnostics11091675
116. Kilikevicius A, Meister G, Corey DR, 2002, Reexamining
105. de Gonzalo-Calvo D, Cenarro A, Civeira F, et al., 2016,
microRNA expression profile in human coronary smooth assumptions about miRNA-guided gene silencing. Nucleic
muscle cell-derived microparticles is a source of biomarkers. Acids Res, 50: 617–634.
Clin Investig Arterioscler, 28: 167–177. https://doi.org/10.1093/nar/gkab1256
https://doi.org/10.1016/j.arteri.2016.05.005 117. Quinn JJ, Chang HY, 2016, Unique features of long non-
coding RNA biogenesis and function. Nat Rev Genet,
106. Vaskova E, Ikeda G, Tada Y, et al., 2020, Sacubitril/valsartan
improves cardiac function and decreases myocardial fibrosis 17: 47–62.
via downregulation of exosomal miR-181a in a rodent https://doi.org/10.1038/nrg.2015.10
chronic myocardial infarction model. J Am Heart Assoc, 9: 118. Wei JW, Huang K, Yang C, et al., 2017, Non-coding RNAs as
e015640.
regulators in epigenetics (Review). Oncol Rep, 37: 3–9.
https://doi.org/10.1161/JAHA.119.015640
https://doi.org/10.3892/or.2016.5236
107. Li J, Cai SX, He Q, et al., 2018, Intravenous miR-144 reduces 119. Fasolo F, Jin H, Winski G, et al., 2021, Long noncoding RNA
left ventricular remodeling after myocardial infarction. MIAT controls advanced atherosclerotic lesion formation
Basic Res Cardiol, 113: 36.
and plaque destabilization. Circulation, 144: 1567–1583.
https://doi.org/10.1007/s00395-018-0694-x
https://doi.org/10.1161/CIRCULATIONAHA.120.052023
108. Gao F, Kataoka M, Liu N, et al., 2019, Therapeutic role of 120. Devaux Y, Zangrando J, Schroen B, et al., 2015, Long
miR-19a/19b in cardiac regeneration and protection from noncoding RNAs in cardiac development and ageing. Nat
myocardial infarction. Nat Commun, 10: 1802.
Rev Cardiol, 12: 415–425.
https://doi.org/10.1038/s41467-019-09530-1
https://doi.org/10.1038/nrcardio.2015.55
109. Gabisonia K, Prosdocimo G, Aquaro GD, et al., 2019, 121. Rezaee M, Masihipour N, Milasi YE, et al., 2023, New
MicroRNA therapy stimulates uncontrolled cardiac repair insights into the long non-coding RNAs dependent
after myocardial infarction in pigs. Nature, 569: 418–422.
modulation of heart failure and cardiac hypertrophy: From
https://doi.org/10.1038/s41586-019-1191-6 molecular function to diagnosis and treatment. Curr Med
Chem, 31: 1404–1426.
110. Roberts TC, Langer R, Wood MJA, 2020, Advances in
oligonucleotide drug delivery. Nat Rev Drug Discov, 19: 673–694. https://doi.org/10.2174/0929867330666230306143351
https://doi.org/10.1038/s41573-020-0075-7 122. Wang Z, Zhang M, Fu Y, 2023, Downregulated circulating

Volume 2 Issue 4 (2023) 19 https://doi.org/10.36922/gtm.1868